- Home
- TRNS vs ABSI Comparison
TRNS vs ABSI Comparison
Compare TRNS & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TRNS | ABSI |
|---|---|---|
| Founded | 1964 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 861.5M | 997.8M |
| IPO Year | 1995 | 2021 |
Fundamental Metrics
Financial Performance| Metric | TRNS | ABSI |
|---|---|---|
| Price | $88.86 | $11.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $116.00 | $6.96 |
| AVG Volume (30 Days) | 178.4K | ★ 7.8M |
| Earning Date | 05-18-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 10.64 |
| EPS | ★ 0.57 | N/A |
| Revenue | ★ $331,877,000.00 | $4,534,000.00 |
| Revenue This Year | $21.75 | $215.96 |
| Revenue Next Year | $7.55 | $319.10 |
| P/E Ratio | $156.19 | ★ N/A |
| Revenue Growth | ★ 19.20 | N/A |
| 52 Week Low | $50.23 | $2.24 |
| 52 Week High | $94.76 | $12.06 |
Technical Indicators
Market Signals| Indicator | TRNS | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 51.54 | 73.95 |
| Support Level | $86.10 | $2.76 |
| Resistance Level | $94.48 | N/A |
| Average True Range (ATR) | 3.75 | 1.05 |
| MACD | -0.58 | 0.34 |
| Stochastic Oscillator | 28.98 | 92.36 |
Price Performance
Historical ComparisonAbout TRNS Transcat Inc.
Transcat Inc is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing services and products to high regulated industries, particularly the life sciences industry, which includes pharmaceutical, biotechnology, medical devices, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. It conducts business through two operating segments: Services and Distribution.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.